As previous post, an 2-minute video in which I describe the fourth of 7 Core #GRADE articles appearing in the #BMJ. This one, published today, shows address #RiskofBias in #SystematicReviews and #Guidelines. #EBM #Medicine #RoB #SR Publication link: bmj.com/content/389/bm…

This fifth article in a seven part series presents the Core GRADE approach to systematic reviews, clinical practice guidelines, and health technology assessments. It also tackles indirect evidence bmj.com/content/389/bm…

Summary of findings tables present the key results of a systematic review. The latest article in the the Core GRADE series outlines how you should approach these summary of findings tables bmj.com/content/389/bm…

🩸💥 Many have asked: “Where did the EAU #thromboprophylaxis guideline go?” Don’t worry. Check out cluevte.org 🚀 ✅ Not just #urology, also #gynecology & abd #surgery ✅ Procedure-specific VTE & bleeding risks ✅ Free interactive tool + static infographics #EBM

🚨Hot off the press in Blood Advances Validation of the CLUE PostSurgery VTE risk instrument Procedure-specific #VTE risks in #surgery, #gynecology & #urology 💻Free tool cluevte.org 📄Open access ashpublications.org/bloodadvances/… #EBM #thromboprophylaxis #ClueWorkingGroup

The living systematic review comprehensively summarising all evidence for all diabetes medications focusing on patient-important outcomes. The BMJ EASD #NMA #T2D #diabetes2025 bmj.com/content/390/bm…

As part of a new Rapid Recommendation, Daniel G Rayner and colleagues summarise evidence on the performance metrics of validated prognosis models on cardiovascular and kidney outcomes in people with type 2 diabetes. Read now: bit.ly/45uZMaY The BMJ #BMJRapidRecs

New living clinical practice guideline: Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes See our #BMJInfographic for a visual summary of the recommendations bmj.com/content/390/bm…

ICYMI: a living #guideline on medications for #diabetes. 1st iteration recently out in The BMJ, accompanied by #SystematicReviews regarding benefits and harms, prognostic models, and patient values and preferences. #SGLT2i #GLP1RA #finerenone #tirzepatide #RapidRecommendation